Wird geladen...
Building on the promise of cancer vaccines for solid tumors
A novel telomerase vaccine (INVAC-1) has been evaluated in a phase I clinical trial (n=26). It induced CD8(+) and CD4(+) T cell responses and reduced circulating regulatory T cells. The findings support further development, especially in combination with vaccine adjuvants, plus therapies to increase...
Gespeichert in:
| Veröffentlicht in: | Clin Cancer Res |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7002281/ https://ncbi.nlm.nih.gov/pubmed/31796513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3206 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|